Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients
- PMID: 21071518
- PMCID: PMC3082414
- DOI: 10.2215/CJN.05540610
Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients
Abstract
Background and objectives: Peritoneal clearance of albumin-unlike the transport of small molecules-is defined by both vascular surface area and size-selective permeability. Few studies have supported a positive correlation between peritoneal albumin loss and mortality. The aim of this study was to investigate whether baseline peritoneal loss and clearance of albumin and other proteins is a risk factor of death in peritoneal dialysis patients.
Design, setting, participants, & measurements: All incident peritoneal dialysis patients in our center during the last 15 years were included. Mass-transfer area coefficient of creatinine and peritoneal clearances of albumin, β₂-microglobulin, α₂-macroglobulin, and immunoglobulin G were calculated during a standard peritoneal permeability analysis. The total amount of albumin loss in the dialysate was also calculated. Overall mortality was studied with an intention-to-treat analysis.
Results: Two hundred fifty-seven patients were included. High baseline albumin clearance was associated with fast transport status, the presence of peripheral arterial disease, and a high comorbidity index, whereas C-reactive protein levels did not differ from the patients with low albumin clearance. Age, high comorbidity score, C-reactive protein levels >10 mg/L, and a low serum albumin were associated with mortality. Peritoneal albumin clearances and albumin loss were not associated with death in crude and adjusted analysis. Similarly, peritoneal clearances of immunoglobulin G, α₂-macroglobulin, and β₂-microglobulin were not determinants of survival.
Conclusions: Baseline peritoneal albumin and protein clearances are associated with signs of comorbidity, but this does not have a measurable effect on patient survival.
Figures

References
-
- Krediet RT, Zuyderhoudt FM, Boeschoten EW, Arisz L: Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients. Nephron 42: 133–140, 1986 - PubMed
-
- Imholz AL, Koomen GC, Voorn WJ, Struijk DG, Arisz L, Krediet RT: Day-to-day variability of fluid and solute transport in upright and recumbent positions during CAPD. Nephrol Dial Transplant 13: 146–153, 1998 - PubMed
-
- Zemel D, Krediet RT, Koomen GC, Struijk DG, Arisz L: Day-to-day variability of protein transport used as a method for analyzing peritoneal permeability in CAPD. Perit Dial Int 11: 217–223, 1991 - PubMed
-
- Krediet RT, Zemel D, Imholz AL, Koomen GC, Struijk DG, Arisz L: Indices of peritoneal permeability and surface area. Perit Dial Int 13: S31–S34, 1993 - PubMed
-
- Kaysen GA: Biological basis of hypoalbuminaemia in ESRD. J Am Soc Nephrol 9: 2368–2376, 1998 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials